<p><strong>What Is DeSci: Challenges and Market Perceptions</strong></p><p></p><p><strong>Authors</strong></p><ul><li><strong>Jelani Clarke, PhD </strong>Executive Lead, DeSci World, and Sales &amp; Marketing Head at AminoChain</li><li><strong>Filippo Frangioni </strong>Product Manager, Novo Nordisk, and Head of Partnerships at Nordic Blockchain Association</li><li><strong>Jim Nasr </strong>CEO, Acoer</li></ul><p></p><p><strong>Themes tackled include:</strong></p><ul><li>The perception problem: Why does DeSci still sound like sci-fi to most scientists?</li><li>Funding friction: Can decentralized models compete with traditional grants and venture capital?</li><li>Data ownership: Who really owns research data, and how can blockchain change that?</li><li>Regulatory roadblocks: What happens when innovation moves faster than policy?</li><li>Real world implementation: Beyond the hype, where is DeSci actually working today?</li></ul><p>From pharmaceutical giants to grassroots research collectives, these leaders shared unfiltered insights on what's holding DeSci back—and what could accelerate its adoption.</p><p><strong>Intrigued?</strong></p><p>This conversation is the first in a <strong>new podcast series launching in 2026</strong> that will dive deeper into the decentralized science revolution. We'll explore:</p><ul><li>Case studies of successful DeSci projects</li><li>Interviews with researchers and policy makers</li><li>Delve into tokenomics, DAOs, and data sovereignty</li><li>The intersection of AI, biotech, and decentralized systems</li></ul><p>The future of science is being built by innovators, technologists, and researchers willing to challenge the status quo.</p>